Morgan Stanley Abiomed Inc Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $6 Million - $7.46 Million	-24,751 Reduced 9.01%	250,016 $61.4 Million
Q2 2022 Oct 27, 2022	BUY	$224.73 - $338.64 $37.3 Million - $56.2 Million	165,956 Added 152.52%	274,767 $68 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $37.3 Million - $56.2 Million	165,956 Added 152.52%	274,767 $68 Million
Q1 2022 Oct 27, 2022	SELL	$277.25 - $366.29 $46 Million - $60.8 Million	-165,956 Reduced 60.4%	108,811 $36 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $2.65 Million - $3.51 Million	9,575 Added 9.65%	108,811 $36 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $363,762 - $449,333	1,210 Added 1.23%	99,236 $35.6 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $30.4 Million - $36.9 Million	98,026 New	98,026 $31.9 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.